Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Traws Pharma, Inc. - Common Stock
(NQ:
TRAW
)
0.6718
+0.0174 (+2.66%)
Streaming Delayed Price
Updated: 11:24 AM EDT, Jul 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Traws Pharma, Inc. - Common Stock
< Previous
1
2
3
4
Next >
12 Health Care Stocks Moving In Monday's After-Market Session
↗
October 27, 2025
Via
Benzinga
Traws Pharma Doses First Patient with Ratutrelvir in Phase 2 COVID Studies, Expects Results by Year-End 2025
October 14, 2025
From
Traws Pharma, Inc.
Via
GlobeNewswire
Traws Pharma Adds John Leaman, MD, as Independent Director and Formalizes Appointments of Two Key Executives
October 06, 2025
From
Traws Pharma, Inc.
Via
GlobeNewswire
Earnings Scheduled For August 14, 2025
↗
August 14, 2025
Via
Benzinga
BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Appoints Mark Guerin as Chief Financial Officer
September 25, 2025
Via
Investor Brand Network
Annovis Appoints Mark Guerin as Chief Financial Officer
September 25, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
September 17, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
September 05, 2025
Via
Benzinga
Traws Pharma Receives Approval to Proceed with Phase 2 COVID Studies with Ratutrelvir, Expects Results by Year-End 2025
August 18, 2025
From
Traws Pharma, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
August 14, 2025
Via
Benzinga
Traws Pharma Posts Q2 Revenue Jump
↗
August 14, 2025
Via
The Motley Fool
Traws Pharma Reports Second Quarter 2025 Results and Business Highlights
August 14, 2025
From
Traws Pharma, Inc.
Via
GlobeNewswire
Traws Pharma to Report Second Quarter 2025 Financial Results on Thursday, August 14, 2025
August 08, 2025
From
Traws Pharma, Inc.
Via
GlobeNewswire
Cooling US Bird Flu Wave Removes Tailwind For Moderna, Novavax, CureVac, Traws Pharma
↗
July 08, 2025
The CDC reportedly deactivated its bird flu emergency response last week, folding surveillance into its regular flu tracking and ending animal infection updates.
Via
Stocktwits
Traws Pharma Advances Antiviral Pipeline with Multiple Regulatory Submissions
June 30, 2025
From
Traws Pharma, Inc.
Via
GlobeNewswire
Why RH Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
↗
June 13, 2025
Via
Benzinga
MAG 8 Momentum: NIVF, TRAW, KPRX, PNPN.V Lead $3 Undercard Surge – More Stocks Inside!
June 04, 2025
Via
AB Newswire
What's going on in today's session
↗
June 03, 2025
Curious to know what's happening on the US markets one hour before the close of the markets on Tuesday? Join us as we explore the top gainers and losers in today's session.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
June 03, 2025
Via
Benzinga
Which stocks are moving on Tuesday?
↗
June 03, 2025
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.
Via
Chartmill
Dow Gains Over 100 Points; US Job Openings Increase In April
↗
June 03, 2025
Via
Benzinga
Topics
Stocks
Tuesday's session: gap up and gap down stocks
↗
June 03, 2025
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday.
Via
Chartmill
US Stocks Mixed; Dollar General Posts Upbeat Earnings
↗
June 03, 2025
Via
Benzinga
Tuesday's pre-market session: top gainers and losers
↗
June 03, 2025
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
June 03, 2025
Via
Benzinga
Traws Pharma Announces Publication of Compelling Efficacy data in RDEB SCC Patients Treated with Legacy Oncology Drug Rigosertib
June 03, 2025
From
Traws Pharma, Inc.
Via
GlobeNewswire
Traws Pharma Announces Receipt of FDA Guidance on Tivoxavir Marboxil and Reports Plans for Pursuing Stockpiling for Pandemic Preparedness
May 27, 2025
From
Traws Pharma, Inc.
Via
GlobeNewswire
Traws Pharma Reports First Quarter 2025 Results and Business Highlights
May 15, 2025
From
Traws Pharma, Inc.
Via
GlobeNewswire
Traws Pharma Reports Full Year 2024 Results and Business Highlights
March 31, 2025
From
Traws Pharma, Inc.
Via
GlobeNewswire
Traws Pharma Announces Management Updates
March 28, 2025
From
Traws Pharma, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
